No fewer than 10 companies have shut down or relocated their operations from Nigeria due to the current economic challenges, ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

Sanofi India Limited (Previously known as Aventis Pharma Limited ... It has its own manufacturing facility at Goa. It sells products through independent distributors primarily in India.Sanofi India's ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

It distributes its products through pharmaceutical wholesale distributors ... The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in ...

The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011 ... Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland ...

Sanofi gets rated buy today ... as it has been driving revenue from multiple products rather than a single magic drug.

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...